Cloud Market Keeps Growing at Over 40%; Amazon Still Increases its Share
Oct 27, 2017 08:00 am UTC| Business
RENO, Nev., Oct. 27, 2017 -- New Q3 data from Synergy Research Group shows that the huge cloud market keeps on growing by over 40% per year while Amazon Web Services (AWS) is still managing to nudge its market share...
THE DIXIE GROUP to Broadcast Its 2017 Third Quarter Earnings Conference Call Live on the Internet
Oct 27, 2017 08:00 am UTC| Business
DALTON, Ga., Oct. 27, 2017 -- THE DIXIE GROUP, INC. (NASDAQ:DXYN) today announced that it will provide an online web simulcast of its 2017 3rd Quarter Earnings conference call on Thursday, November 9th, 2017 at 1:30...
Customer-facing IPsoft Amelia implementation at SEB wins AI innovation award
Oct 27, 2017 07:30 am UTC| Business
NEW YORK, Oct. 27, 2017 -- Nicolas Moch, Head of Information, Architecture and Strategy for SEB, the leading Nordic corporate bank, is the winner of this year’s Supernova Award from Constellation Research in the...
Oct 27, 2017 05:45 am UTC| Business
PARIS, France, Oct. 27, 2017 -- BIOPHYTIS (Euronext Growth Paris:ALBPS), a biotechnology company focused on innovative therapeutics to restore the muscular and visual functions in diseases with significant unmet medical...
REXEL : THIRD-QUARTER AND NINE-MONTH 2017 RESULTS
Oct 27, 2017 05:31 am UTC| Business
THIRD-QUARTER NINE-MONTH 2017 RESULTS ACCELERATING SAME-DAY SALES IN Q3, UP 5.2% IMPROVING PROFITABILITY IN Q3 WHILE INVESTING IN THE US FULL YEAR TARGETS CONFIRMED - SALES OF €3.239bn IN Q3, UP 1.4%...
Soft Tissue Repair Market Size Will Reach USD 17.12 Billion by 2021, Globally: Zion Market Research
Oct 27, 2017 05:31 am UTC| Business
Sarasota, FL, Oct. 27, 2017 -- Zion Market Research has published a new report titled “Soft Tissue Repair Market (Mesh/Tissue Patch, Soft Tissue Fixation Devices, Laparoscopic Instruments and Others) for Skin Repair,...
Oct 27, 2017 05:02 am UTC| Business
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 27 October 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX], a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody®...